Treatment and longitudinal follow-up of CNV associated with pattern dystrophy with novel


Journal

Ophthalmic genetics
ISSN: 1744-5094
Titre abrégé: Ophthalmic Genet
Pays: England
ID NLM: 9436057

Informations de publication

Date de publication:
12 2021
Historique:
pubmed: 7 9 2021
medline: 5 2 2022
entrez: 6 9 2021
Statut: ppublish

Résumé

Peripherin-2 (PRPH2) is a transmembrane glycoprotein crucial for the morphogenesis and stabilization of the photoreceptor outer segments. Variations in Clinical manifestations and multimodal imaging were presented, as well as treatment history and six-year follow-up. In addition, genetic testing was performed to confirm the diagnosis. In this report, we present an extremely rare case of choroidal neovascularization (CNV) secondary to pattern dystrophy simulating fundus flavimaculatus (PDSFF). Multimodal imaging showed typical symmetric yellow flecks in posterior pole and choroidal neovascularization requiring timely treatment. A novel nonsense variant of c.552 C > G; p.Y184X in We described a novel

Sections du résumé

BACKGROUND
Peripherin-2 (PRPH2) is a transmembrane glycoprotein crucial for the morphogenesis and stabilization of the photoreceptor outer segments. Variations in
METHODS
Clinical manifestations and multimodal imaging were presented, as well as treatment history and six-year follow-up. In addition, genetic testing was performed to confirm the diagnosis.
RESULTS
In this report, we present an extremely rare case of choroidal neovascularization (CNV) secondary to pattern dystrophy simulating fundus flavimaculatus (PDSFF). Multimodal imaging showed typical symmetric yellow flecks in posterior pole and choroidal neovascularization requiring timely treatment. A novel nonsense variant of c.552 C > G; p.Y184X in
CONCLUSION
We described a novel

Identifiants

pubmed: 34486473
doi: 10.1080/13816810.2021.1952617
doi:

Substances chimiques

Angiogenesis Inhibitors 0
Codon, Nonsense 0
Coloring Agents 0
PRPH2 protein, human 0
Peripherins 0
VEGFA protein, human 0
Vascular Endothelial Growth Factor A 0
Indocyanine Green IX6J1063HV
Ranibizumab ZL1R02VT79

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

768-772

Auteurs

Jingjing Xu (J)

School of Medicine, Tsinghua University, Beijing, China.

Kang Li (K)

Department of Ophthalmology, Beijing Hospital, Beijing, China.

Bodi Zheng (B)

Department of Ophthalmology, Beijing Hospital, Beijing, China.

Hong Dai (H)

Department of Ophthalmology, Beijing Hospital, Beijing, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH